Daniel Morgensztern
Impact in
- Oncology top 0.2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Papers in
- Oncology 158
- Lung Cancer Research Studies 84
- Cancer Immunotherapy and Biomarkers 39
- Peptidase Inhibition and Analysis 18
-
- Lung Cancer Treatments and Mutations 109
- Lung Cancer Diagnosis and Treatment 45
- Co-authors
- Roy S. HerbstChris BoshoffRamaswamy GovindanSaiama N. WaqarJay F. PiccirilloFeng GaoHoward L. McLeodAnna Vlahiotis
- Journals
- Journal of Clinical Oncology (65 papers)Journal of Thoracic Oncology (35 papers)Annals of Oncology (14 papers)Clinical Lung Cancer (9 papers)Clinical Cancer Research (7 papers)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Daniel Morgensztern
216 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 5.4k
- Cancer Research 2.2k
- Pulmonary and Respiratory Medicine 4.5k
- Molecular Biology 3.9k
- Epidemiology 1.9k
Countries citing papers authored by Daniel Morgensztern
This map shows the geographic impact of Daniel Morgensztern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Morgensztern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Morgensztern more than expected).
Fields of papers citing papers by Daniel Morgensztern
This network shows the impact of papers produced by Daniel Morgensztern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Morgensztern. The network helps show where Daniel Morgensztern may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Morgensztern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 11 | |
| 8 | 2021 | 60 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 4 | |
| 11 | 2019 | 229 | |
| 12 | 2019 | 41 | |
| 13 | 2019 | 19 | |
| 14 | 2018 | 3 | |
| 15 | 2018 | 104 | |
| 16 | 2016 | 11 | |
| 17 | 2015 | 24 | |
| 18 | 2011 | 1 | |
| 19 | 2010 | 2 | |
| 20 | 2010 | 48 |
About Daniel Morgensztern
Daniel Morgensztern is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Microbiology and Otorhinolaryngology, having authored 228 papers that have together received 10.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (109 papers), Lung Cancer Research Studies (84 papers), Lung Cancer Diagnosis and Treatment (45 papers), Cancer Immunotherapy and Biomarkers (39 papers), Cancer Genomics and Diagnostics (26 papers), Neuroendocrine Tumor Research Advances (25 papers), Cancer therapeutics and mechanisms (20 papers) and Peptidase Inhibition and Analysis (18 papers). The work is most often cited by research in Oncology (5.4k citations), Cancer Research (2.2k citations), Pulmonary and Respiratory Medicine (4.5k citations), Molecular Biology (3.9k citations) and Epidemiology (1.9k citations). Daniel Morgensztern has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Roy S. Herbst, Chris Boshoff, Ramaswamy Govindan, Saiama N. Waqar, Jay F. Piccirillo, Feng Gao, Howard L. McLeod, Anna Vlahiotis, William L. Read and Nathan Page. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Clinical Lung Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.